Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: comparison of event rates in routine clinical practice and a clinical trial

References

• Lau YJ, Sung J, Hill C, Henderson C, Howden CW, Metz DC. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion 2011;84:102–13.
   PubMed Web of Science ®Google Scholar
• Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel M, International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2010;152:101–13.
   PubMed Web of Science ®Google Scholar
• Sung JJ, Barkun A, Kuipers EJ, Mossner J, Jensen DM, Stuart R, Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med 2009;150:455–64.
   PubMed Web of Science ®Google Scholar
• Leontiadis GI, Martin J, Sharma VK, Howden CW. Proton pump inhibitor (PPI) treatment for peptic ulcer (PU) bleeding: an updated Cochrane meta-analysis of randomized controlled trials (RCTs). Gastroenterology 2009;136:A–605.
   Google Scholar
• Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2006;CD002094.
   PubMed Web of Science ®Google Scholar
• Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet 2005;365:82–93.
   PubMed Web of Science ®Google Scholar
• Travers J, Marsh S, Caldwell B, Williams M, Aldington S, Weatherall M, External validity of randomized controlled trials in COPD. Respir Med 2007;101:1313–20.
   PubMed Web of Science ®Google Scholar
• Fein F, Weber A, Koch S, Festou N, Dupont-Gossard AC, Cervoni JP, The prognosis of patients having received optimal therapy for nonvariceal upper gastrointestinal bleeding might be worse in daily practice than in randomized clinical trials. Eur J Gastroenterol Hepatol 2010;22:361–7.
   PubMedGoogle Scholar
• Lanas A, Perez-Aisa MA, Feu F, Ponce J, Saperas E, Santolaria S, A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol 2005;100:1685–93.
   PubMed Web of Science ®Google Scholar
• Lanas A, Garcia-Rodriguez LA, Polo-Tomas M, Ponce M, Alonso-Abreu I, Perez-Aisa MA, Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol 2009;104:1633–41.
   PubMed Web of Science ®Google Scholar
• Lanas A, Tafalla M, Nuevo J. Predictors of mortality among patients with non-variceal upper gastrointestinal bleeding: an observational European study. Am J Gastroenterol 2009;104(Suppl 3):P24.
   Google Scholar
• Lanas A, Aabakken L, Fonseca J, Mungan ZA, Papatheodoridis GV, Piessevaux H, Clinical predictors of poor outcomes among patients with nonvariceal upper gastrointestinal bleeding in Europe. Aliment Pharmacol Ther 2011;33:1225–33.
   PubMed Web of Science ®Google Scholar
• Sung JJ, Mossner J, Barkun A, Kuipers EJ, Lau J, Jensen D, Intravenous esomeprazole for prevention of peptic ulcer re-bleeding: rationale/design of Peptic Ulcer Bleed study. Aliment Pharmacol Ther 2008;27:666–77.
   PubMed Web of Science ®Google Scholar
• Lau JY, Sung JJ, Metz DC, Howden CW. Systematic review of the epidemiology of complicated peptic ulcer: incidence, recurrence, risk factors and mortality. Gastroenterology 2008;134(4 Suppl 1):A32.
   Google Scholar
• Lanas A, Munoz M, Caballero Correa M, Martinez Jimenez P. Analysis of differences between indication and prescription of gastroprotection in patients with risk factors treated with nonsteroidal anti-inflammatory agents: the GAP study. Gastroenterol Hepatol 2010;33:80–91.
   PubMedGoogle Scholar
• Sreedharan A, Martin J, Leontiadis GI, Forman D, Howden CW, Moayyedi P. Does proton pump inhibitor (PPI) treatment initiated before endoscopy work in unselected upper gastrointestinal bleeding? A Cochrane systematic review update. Gastroenterology 2009;136(Suppl 1):229.
   Google Scholar
• Evans JP, Smith R. Predicting poor outcome in perforated peptic ulcer disease. Aust N Z J Surg 1997;67:792–5.
   PubMedGoogle Scholar
• Hasselgren G, Carlsson J, Lind T, Schaffalitzky de Muckadell O, Lundell L. Risk factors for rebleeding and fatal outcome in elderly patients with acute peptic ulcer bleeding. Eur J Gastroenterol Hepatol 1998;10:667–72.
   PubMed Web of Science ®Google Scholar
• Bini EJ, Cohen J. Endoscopic treatment compared with medical therapy for the prevention of recurrent ulcer hemorrhage in patients with adherent clots. Gastrointest Endosc 2003;58:707–14.
   PubMedGoogle Scholar
• Weil J, Langman MJ, Wainwright P, Lawson DH, Rawlins M, Logan RF, Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut 2000;46:27–31.
   PubMed Web of Science ®Google Scholar
• Muller P, Arce L, Jackisch P, Simon B. Circadian aspects of acetylsalicylic acid induced injury and protective effect of ranitidine on the upper gastrointestinal tract. Arzneimittelforschung 1994;44:962–5.
   PubMedGoogle Scholar